A critical pathway to treat proximal lower-extremity deep vein thrombosis
- 1 March 1996
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 100 (3) , 283-289
- https://doi.org/10.1016/s0002-9343(97)89486-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Thrombophilia: the new factor is old factor VThe Lancet, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Acenocoumarol and Heparin Compared with Acenocoumarol Alone in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1992
- Efficacy and safety of early versus late initiation of warfarin during heparin therapy in acute thromboembolismAmerican Heart Journal, 1992
- Oral Anticoagulant DrugsNew England Journal of Medicine, 1991
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous ThrombosisNew England Journal of Medicine, 1990
- SAFETY AND EFFICACY OF WARFARIN STARTED EARLY AFTER SUBMASSIVE VENOUS THROMBOSIS OR PULMONARY EMBOLISMThe Lancet, 1986
- Audit of control of heparin treatment.BMJ, 1985
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982
- The organisation of experimental venous thrombiThe Journal of Pathology and Bacteriology, 1958